10,858 Shares in iShares Global Healthcare ETF $IXJ Bought by Park Avenue Securities LLC

Park Avenue Securities LLC purchased a new position in shares of iShares Global Healthcare ETF (NYSEARCA:IXJ) during the third quarter, Holdings Channel reports. The institutional investor purchased 10,858 shares of the company’s stock, valued at approximately $1,109,000.

Other hedge funds have also bought and sold shares of the company. Segment Wealth Management LLC purchased a new position in shares of iShares Global Healthcare ETF in the 3rd quarter worth about $218,000. Miller Howard Investments Inc. NY purchased a new stake in iShares Global Healthcare ETF during the third quarter worth about $8,796,000. Leo Wealth LLC bought a new stake in iShares Global Healthcare ETF in the third quarter worth about $4,020,000. Mondrian Investment Partners LTD bought a new stake in iShares Global Healthcare ETF in the third quarter worth about $1,047,000. Finally, Manchester Capital Management LLC bought a new stake in iShares Global Healthcare ETF in the third quarter worth about $204,000.

iShares Global Healthcare ETF Trading Down 0.1%

NYSEARCA:IXJ opened at $112.57 on Tuesday. The stock has a market capitalization of $4.65 billion, a PE ratio of 21.58 and a beta of 0.55. The firm’s 50 day moving average is $104.93 and its 200 day moving average is $99.09. iShares Global Healthcare ETF has a 12 month low of $90.28 and a 12 month high of $114.06.

iShares Global Healthcare ETF Company Profile

iShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor’s Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.